These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 37126968)
1. Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands. Xu H; Kurohara T; Ohoka N; Tsuji G; Inoue T; Naito M; Demizu Y Bioorg Med Chem; 2023 May; 86():117293. PubMed ID: 37126968 [TBL] [Abstract][Full Text] [Related]
2. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders. Setia N; Almuqdadi HTA; Abid M Eur J Med Chem; 2024 Feb; 265():116041. PubMed ID: 38199162 [TBL] [Abstract][Full Text] [Related]
3. Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins. Yokoo H; Tsuji G; Inoue T; Naito M; Demizu Y; Ohoka N Bioorg Chem; 2024 Apr; 145():107204. PubMed ID: 38377822 [TBL] [Abstract][Full Text] [Related]
4. E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points. Bricelj A; Steinebach C; Kuchta R; Gütschow M; Sosič I Front Chem; 2021; 9():707317. PubMed ID: 34291038 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands. Cheng W; Li S; Han S; Miao R; Wang S; Liu C; Wei H; Tian X; Zhang X Bioorg Med Chem; 2023 Mar; 82():117237. PubMed ID: 36906965 [TBL] [Abstract][Full Text] [Related]
6. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs. Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187 [TBL] [Abstract][Full Text] [Related]
7. A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation. Wurz RP; Dellamaggiore K; Dou H; Javier N; Lo MC; McCarter JD; Mohl D; Sastri C; Lipford JR; Cee VJ J Med Chem; 2018 Jan; 61(2):453-461. PubMed ID: 28378579 [TBL] [Abstract][Full Text] [Related]
8. E3 ligase ligand optimization of Clinical PROTACs. Jiang H; Xiong H; Gu SX; Wang M Front Chem; 2023; 11():1098331. PubMed ID: 36733714 [TBL] [Abstract][Full Text] [Related]
9. A beginner's guide to current synthetic linker strategies towards VHL-recruiting PROTACs. Zografou-Barredo NA; Hallatt AJ; Goujon-Ricci J; Cano C Bioorg Med Chem; 2023 Jun; 88-89():117334. PubMed ID: 37224698 [TBL] [Abstract][Full Text] [Related]
10. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones. Ishida T; Ciulli A SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537 [TBL] [Abstract][Full Text] [Related]
11. Development of Rapid and Facile Solid-Phase Synthesis of PROTACs via a Variety of Binding Styles. Xu H; Kurohara T; Takano R; Yokoo H; Shibata N; Ohoka N; Inoue T; Naito M; Demizu Y ChemistryOpen; 2022 Jul; 11(7):e202200131. PubMed ID: 35822913 [TBL] [Abstract][Full Text] [Related]
12. A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions. Guo L; Zhou Y; Nie X; Zhang Z; Zhang Z; Li C; Wang T; Tang W Eur J Med Chem; 2022 Jun; 236():114317. PubMed ID: 35397401 [TBL] [Abstract][Full Text] [Related]
13. [Development of Protein Knockdown Technology as Emerging Drug Discovery Strategy]. Ohoka N Yakugaku Zasshi; 2018; 138(9):1135-1143. PubMed ID: 30175757 [TBL] [Abstract][Full Text] [Related]
14. Discovery of E3 Ligase Ligands for Target Protein Degradation. Lee J; Lee Y; Jung YM; Park JH; Yoo HS; Park J Molecules; 2022 Oct; 27(19):. PubMed ID: 36235052 [TBL] [Abstract][Full Text] [Related]
15. A Modular Chemistry Platform for the Development of a Cereblon E3 Ligase-Based Partial PROTAC Library. Almodóvar-Rivera CM; Zhang Z; Li J; Xie H; Zhao Y; Guo L; Mannhardt MG; Tang W Chembiochem; 2023 Oct; 24(20):e202300482. PubMed ID: 37418320 [TBL] [Abstract][Full Text] [Related]
16. Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs. Shah RR; De Vita E; Sathyamurthi PS; Conole D; Zhang X; Fellows E; Dickinson ER; Fleites CM; Queisser MA; Harling JD; Tate EW J Med Chem; 2024 Mar; 67(6):4641-4654. PubMed ID: 38478885 [TBL] [Abstract][Full Text] [Related]
17. CRBN ligand expansion for hematopoietic prostaglandin D Osawa H; Kurohara T; Ito T; Shibata N; Demizu Y Bioorg Med Chem; 2023 Apr; 84():117259. PubMed ID: 37018877 [TBL] [Abstract][Full Text] [Related]